Real-world feasibility of co-administration of RSV, COVID-19, and influenza vaccines in older adults: a VAERS-based analysis.

ABSTRACT:

Background

Respiratory syncytial virus (RSV), COVID-19, and seasonal influenza represent significant health threats to older adults. These pathogens frequently co-circulate during the same seasons. Co-administration of vaccines targeting these viruses is a practical strategy to enhance vaccination coverage and convenience. However, real-world safety data on the simultaneous administration of RSV, COVID-19, and influenza vaccines in adults aged 60 and older remain limited.

Objective

This study aimed to explore the safety profile of co-administration of RSV, COVID-19, and influenza vaccines in adults aged 60 and older. Using data from the U.S. Vaccine Adverse Event Reporting System (VAERS), the study aimed to identify patterns of adverse events following immunization (AEFIs) a

SUBMITTER: Wei Z 

PROVIDER: S-EPMC12580320 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature